Page last updated: 2024-08-24

ibandronic acid and Bone Marrow Diseases

ibandronic acid has been researched along with Bone Marrow Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Fehr, T; Jeker, R; Küchler, L1
Appelt, KA; Meier, C; Müller, F; Suhm, N1
Friederich, NF; Grize, L; Kraenzlin, C; Kraenzlin, ME; Meier, C; Meier, CR; Wischer, T1
Amling, M; Barvencik, F; Luttke, M; Mueller-Wohlfahrt, HW; Simon, MJ; Ueblacker, P1
Li, JF; Yan, JY1
Bartl, C; Bartl, R; Imhoff, A1

Trials

1 trial(s) available for ibandronic acid and Bone Marrow Diseases

ArticleYear
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Volume: 25, Issue:1

    Topics: Adult; Aged; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Double-Blind Method; Edema; Female; Follow-Up Studies; Humans; Ibandronic Acid; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Osteonecrosis; Pain Measurement; Severity of Illness Index; Treatment Outcome; Young Adult

2014

Other Studies

5 other study(ies) available for ibandronic acid and Bone Marrow Diseases

ArticleYear
Pain control with ibandronate for bone marrow oedema of the knee.
    Swiss medical weekly, 2020, Nov-16, Volume: 150

    Topics: Bone Marrow; Bone Marrow Diseases; Diphosphonates; Edema; Humans; Ibandronic Acid; Magnetic Resonance Imaging; Pain; Prospective Studies; Retrospective Studies

2020
Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2020, Volume: 28, Issue:2

    Topics: Aged; Arthralgia; Biomarkers; Bone Density Conservation Agents; Bone Marrow Diseases; Collagen Type I; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Retrospective Studies; Vitamin D; Zoledronic Acid

2020
Intravenous bisphosphonates and vitamin D in the treatment of bone marrow oedema in professional athletes.
    Injury, 2014, Volume: 45, Issue:6

    Topics: Adult; Athletes; Bone Density; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Edema; Female; Fractures, Stress; Humans; Ibandronic Acid; Injections, Intravenous; Magnetic Resonance Imaging; Male; Syndrome; Treatment Outcome; Vitamin D

2014
[Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2009, Volume: 22, Issue:9

    Topics: Adult; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Female; Femur Head Necrosis; Hip Joint; Humans; Ibandronic Acid; Male; Middle Aged

2009
Treatment of bone marrow edema syndrome with intravenous ibandronate.
    Archives of orthopaedic and trauma surgery, 2012, Volume: 132, Issue:12

    Topics: Adolescent; Adult; Bone Marrow Diseases; Diphosphonates; Edema; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Pilot Projects; Prospective Studies; Syndrome; Talus; Young Adult

2012